SAN DIEGO, Sept. 16, 2019 /PRNewswire/ -- Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patie

MAHWAH, N.J., Sept. 16, 2019 /PRNewswire/ -- Glenmark Pharmaceuticals (Glenmark), a research-led, integrated global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma who have received prior thera

SALT LAKE CITY, Sept. 16, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that D

WASHINGTON, Sept. 16, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers

BOSTON, Sept. 16, 2019 /PRNewswire/ -- Firefly Health, a technology-powered concierge medicine service for average Americans, announced today it has closed $10.2 mi

BOTHELL, Wash. and TOKYO, Sept. 16, 2019 /PRNewswire/ -- Seattle Genetics, Inc. (Nasdaq:SGEN) and

ST. LOUIS, Sept. 16, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Cantor Global Healthcare Conference, to be held October 2-4, 2019, at the Intercontinental New York Barclay Hotel in New York City. Centene will present on Thursd

ABBOTT PARK, Ill. and PARIS, Sept. 16, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary

ATLANTA, Sept. 16, 2019 /PRNewswire/ -- Jackson Physician Search, a firm specializing in the permanent recruitment of physicians and advanced practice providers to hos

SAN DIEGO, Sept. 16, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) ("Alder") breached their fiduciary duties in connection with the proposed sale of the Company to Danish pharmaceutical company Lundbeck.On Sept